Skip to content

Climb Bio, Inc. CLYM Other Income (Expense)

Other Income (Expense) at other companies

Amgen logo
AmgenAMGN
$75M-95.1%
Vera Therapeutics logo
Vera TherapeuticsVERA
$4.1M-25.5%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$1.64M-40.9%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$62K+27.1%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$3.09M+121%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$778K+13.2%

Other financials

Income statement

See full
Operating income-$15.2M+33.9%
Net income-$13.7M+34.0%
EPS (diluted)-$0.20+35.5%

Balance sheet

See full
Cash & equivalents$8.4M-71.2%
Total debt$479.0K+1.1%
Total equity$148.1M-23.4%
Total assets$152.4M-24.1%

Cash flow

See full
Operating cash flow-$14.4M+6.8%
CapEx$109.0K
Free cash flow-$15.6M-183%

Valuation

See full
Market cap$724.95M+787%
Enterprise value$717.07M+1,247%

Returns & leverage

See full
Return on equity-30.9%-10.3pp
Debt / equity0.0×
Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Climb Bio, Inc.'s other income (expense)?
Climb Bio, Inc. (CLYM) reported other income (expense) of $1.49M in Q1 2026.
How has Climb Bio, Inc.'s other income (expense) changed year-over-year?
Climb Bio, Inc.'s other income (expense) decreased by 33.4% year-over-year, from $2.24M to $1.49M.
What is the long-term trend for Climb Bio, Inc.'s other income (expense)?
Over 3 years (2021 to 2025), Climb Bio, Inc.'s other income (expense) has grown at a -12.4% compound annual growth rate (CAGR), from -$11.97M to $8.03M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.